ZA891441B - 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion - Google Patents

4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion

Info

Publication number
ZA891441B
ZA891441B ZA891441A ZA891441A ZA891441B ZA 891441 B ZA891441 B ZA 891441B ZA 891441 A ZA891441 A ZA 891441A ZA 891441 A ZA891441 A ZA 891441A ZA 891441 B ZA891441 B ZA 891441B
Authority
ZA
South Africa
Prior art keywords
acylquinolene
inhibitors
derivatives
amino
gastric secretion
Prior art date
Application number
ZA891441A
Other languages
English (en)
Inventor
Robert John Ife
John Ife Robert
Thomas Henry Brown
Henry Brown Thomas
Colin Andrew Leach
Andrew Leach Colin
Original Assignee
Smithkline Beckman Intercredit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Intercredit filed Critical Smithkline Beckman Intercredit
Publication of ZA891441B publication Critical patent/ZA891441B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA891441A 1988-02-25 1989-02-24 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion ZA891441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888804446A GB8804446D0 (en) 1988-02-25 1988-02-25 Compounds

Publications (1)

Publication Number Publication Date
ZA891441B true ZA891441B (en) 1989-11-29

Family

ID=10632378

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891441A ZA891441B (en) 1988-02-25 1989-02-24 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion

Country Status (8)

Country Link
US (1) US5082848A (da)
EP (1) EP0331357A1 (da)
JP (1) JPH01261373A (da)
AU (1) AU3011689A (da)
DK (1) DK82089A (da)
GB (1) GB8804446D0 (da)
PT (1) PT89791A (da)
ZA (1) ZA891441B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US20050167547A1 (en) * 2004-02-02 2005-08-04 Mclellan Robin S. Magnetized mounting bracket

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2652398A (en) * 1949-11-17 1953-09-15 Endo Products Inc N-substituted-2-amino (methyl) quinolines
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds

Also Published As

Publication number Publication date
GB8804446D0 (en) 1988-03-23
JPH01261373A (ja) 1989-10-18
DK82089D0 (da) 1989-02-22
AU3011689A (en) 1989-08-31
US5082848A (en) 1992-01-21
PT89791A (pt) 1989-10-04
DK82089A (da) 1989-08-26
EP0331357A1 (en) 1989-09-06

Similar Documents

Publication Publication Date Title
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
HU9303251D0 (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU3181989A (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
PL278545A1 (en) Method of obtaining novel derivatives of cyclobutylpurine and cyclobutylpyrimidine
EP0532466A3 (en) Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
EG18128A (en) Process for preparation of substituted thienoimidazole derivatives and their use as inhibitors of gastric acid secretion
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
HU893412D0 (en) Inhibitors of interleucin-1
EG18822A (en) Production and use of prophyrins
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
ZA891442B (en) Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion
GB2333292B (en) Derivatives of hexaazoisowurtzitane
IL89534A0 (en) Preparation of 1-cyclopropyl-quinolone-carboxylic acids and derivatives thereof and certain novel n-cyclopropyl-anilines used therein
GB2205745B (en) Use of dioxopiperidine derivatives as analgesics
AU7465487A (en) Benzimidazole derivatives and their use as gastric acid secretion inhibitors
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
AU3494293A (en) Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
ZA898741B (en) Use of azepinone derivatives
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
GB2225113B (en) State of fill-determining apparatus
ZA929568B (en) 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion
IL92419A0 (en) Derivatives of benzoxazimes and pharmaceutical compositions containing them
PH22427A (en) Eburnamenine derivatives and method of use thereof
IE883765L (en) Derivatives of thioformamide
IL89907A0 (en) New use of tetrazole derivatives